Leading industry, government and legal experts will meet in Denver next month to discuss the marketing of drugs and medical devices. The event is being hosted by the Regulatory Affairs Professionals Society (RAPS).
The latest regulations, guidelines and trends affecting the advertising and promotion of medical devices, drugs and biologics will be among the primary issues discussed at the upcoming Advertising, Promotion and Labeling Conference on May 1 and 2.
The event will feature advertising and promotion of medical devices and prescription drugs and biologics in its annual platform. The focus of the conference comes in response to an evolving regulatory environment for device and drug advertising and promotion under new FDA regulations, industry initiatives and multimillion-dollar settlements, according to RAPS Executive Director Sherry L. Keramidas.